647029-92-3

Basic information

• Product Name: {2-[(8bS,9aS,10S,13R,13aR,14aS)-10-(2-Benzyloxy-ethoxy)-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy]-ethoxy}-tert-butyl-diphenyl-silane
• Synonyms: {2-[(8bS,9aS,10S,13R,13aR,14aS)-10-(2-Benzyloxy-ethoxy)-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy]-ethoxy}-tert-butyl-diphenyl-silane
• CAS NO: 647029-92-3
• Molecular Weight: 889.171
• Mol File: 647029-92-3.mol

Chemical Properties

• CAS DataBase Reference: {2-[(8bS,9aS,10S,13R,13aR,14aS)-10-(2-Benzyloxy-ethoxy)-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy]-ethoxy}-tert-butyl-diphenyl-silane(CAS DataBase Reference)
• NIST Chemistry Reference: {2-[(8bS,9aS,10S,13R,13aR,14aS)-10-(2-Benzyloxy-ethoxy)-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy]-ethoxy}-tert-butyl-diphenyl-silane(647029-92-3)
• EPA Substance Registry System: {2-[(8bS,9aS,10S,13R,13aR,14aS)-10-(2-Benzyloxy-ethoxy)-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy]-ethoxy}-tert-butyl-diphenyl-silane(647029-92-3)

Safety Data

• Hazardous Substances Data: 647029-92-3(Hazardous Substances Data)

Upstream product

• 1462-37-9 bromoethyl-2-benzyl ether 
• 647029-91-2 (8bS,9aR,10R,13S,13aR,14aS)-12-[2-(tert-Butyl-diphenyl-silanyloxy)-ethoxy]-10-isobutoxymethyl-8b,14a-dimethoxy-8b,9a,12,13,13a,14a-hexahydro-10H-9,11,14-trioxa-benzo[b]triphenylen-13-ol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 647029-90-1 [2-((8bS,9aS,10S,13R,13aR,14aS)-10-Benzyloxy-13-isobutoxymethyl-8b,14a-dimethoxy-8b,10,11,13,13a,14a-hexahydro-9aH-9,12,14-trioxa-benzo[b]triphenylen-11-yloxy)-ethoxy]-tert-butyl-diphenyl-silane 

Relevant articles and documents

Synthesis and Structure - Activity Relationship of Mannose-Based Peptidomimetics Selectively Blocking Integrin α4β7 Binding to Mucosal Addressin Cell Adhesion Molecule-1

As part of our ongoing research in the development of α4β7 integrin antagonists, we are interested in peptidomimetics based on a rigid scaffold to allow the display of essential side chains in a suitable binding conformation while eliminating backbone ami